Getting to know GLP-1 receptor agonists
The latest Pearls from I.M. Peers offers advice on prescribing glucagon-like peptide-1 (GLP-1) receptor agonists for patients with diabetes.
The March edition of Pearls from I.M. Peers brings advice from endocrinologist Sanam Lathief, MD, FACP, on prescribing glucagon-like peptide-1 (GLP-1) receptor agonists for patients with diabetes.
Pearls from I.M. Peers is a monthly feature in ACP Internist that provides a particular internal medicine physician's best clinical pearl or solution to a problem, with associated video online, allowing ACP members a chance to offer clinical wisdom in their own words. This month, Dr. Lathief explains the function, benefits, and risks of GLP-1 receptor agonists.